Work

Prevalence of pathogenic germline risk variants (PVs) in 1,829 renal cell carcinoma (RCC) patients (pts).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.6_suppl.659

Authors: Sarah Abou Alaiwi, Amin Nassar, Elio Adib, Elie Akl, Stefan Groha, Edward D. Esplin, Sarah Nielsen, Shan Yang, Bradley Alexander McGregor, Mark Pomerantz, Alexander Gusev, Huma Q. Rana, Guru Sonpavde, Judy Ellen Garber, Matthew L. Freedman, Toni K. Choueiri

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Stanford Medicine, Stanford University, Invitae (United States), Harvard University, Dana-Farber Brigham Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3007526417

Cites:

Cited by: 1

Related to: 10